资讯
1 天on MSN
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
Novavax (NVAX) stock in focus as the U.S. FDA approves its COVID-19 vaccine Nuvaxovid for high-risk groups in the U.S. Read ...
(Reuters) -Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 ...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...
The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...
After a prolonged wait, American company Novavax (Nasdaq: NVAX) has received full approval from the US regulator for its ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
Gaithersburg’s Novavax has secured formal regulatory approval for its Covid vaccine. It's a major win, after the FDA delayed ...
Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics ...
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
当前正在显示可能无法访问的结果。
隐藏无法访问的结果